Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 22, 2014
Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies
Li Xu, Matthias Port, Stefano Landi, et al.
Plos One
|
September 24, 2015
Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role?
Valentina M Drozd, Vladimir A Saenko, Alina V Brenner, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 21, 2010
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination
Randa M Abdulrahman, Herman Verloop, Hendrieke Hoftijzer, et al.
The Lancet. Oncology
|
October 11, 2018
Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC
Kayo Togawa, Hyeong Sik Ahn, Anssi Auvinen, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 11, 2018
Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids
Carolien M Beukhof, Elske T Massolt, Theo J Visser, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 18, 2008
Expanding indications for recombinant human TSH in thyroid cancer
Bryan R Haugen, David S Cooper, Charles H Emerson, et al.
European Journal of Endocrinology
|
June 9, 2020
Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors
Hanneke M van Santen, Erik K Alexander, Scott A Rivkees, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 6, 2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal
Heribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Carcinogenesis
|
May 22, 2016
Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population
Alice J Sigurdson, Alina V Brenner, James A Roach, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 22, 2014
Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies
Li Xu, Matthias Port, Stefano Landi, et al.
Plos One
|
September 24, 2015
Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role?
Valentina M Drozd, Vladimir A Saenko, Alina V Brenner, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 21, 2010
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination
Randa M Abdulrahman, Herman Verloop, Hendrieke Hoftijzer, et al.
The Lancet. Oncology
|
October 11, 2018
Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC
Kayo Togawa, Hyeong Sik Ahn, Anssi Auvinen, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 11, 2018
Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids
Carolien M Beukhof, Elske T Massolt, Theo J Visser, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 18, 2008
Expanding indications for recombinant human TSH in thyroid cancer
Bryan R Haugen, David S Cooper, Charles H Emerson, et al.
European Journal of Endocrinology
|
June 9, 2020
Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors
Hanneke M van Santen, Erik K Alexander, Scott A Rivkees, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 6, 2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal
Heribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Carcinogenesis
|
May 22, 2016
Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population
Alice J Sigurdson, Alina V Brenner, James A Roach, et al.
Page
of 14